Breast cancer patients often face the additional risk of distant metastases, and the best way to find the presence of those abnormalities in the liver and bone is with PET/MRI, according to a study published in the October issue of Radiology. {read more here}

Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.  {read more here}

Axumin is a molecular imaging agent indicated for use in PET imaging in men with suspected prostate cancer recurrence based on elevated blood levels of prostate-specific antigen (PSA) following prior treatment. Results of the multicenter study demonstrated a 68% overall detection rate for Axumin, with the ability to detect local and distant prostate cancer recurrence across a range of PSA values, the firm said. {read more here}

Researchers at Stanford University have demonstrated for the first time the use of a dual optical and PET/CT activity-based probe to detect atherosclerotic plaques. The study is published in the October issue of the Journal of Nuclear Medicine. {read more here}